Skip to main content
SpringerLink
Log in

Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

In vitro growth and differentiation of granulocyte-macrophage progenitor cells (GM-CFU-C) requires colony-stimulating factors (CSF), and an in vivo role for CSF has also been proposed. Prostaglandins of the E series (PGE) have been reported to serve as negative feedback regulators of myelopoiesis. Here, we report evidence of augmented CSF secretion by mouse peritoneal Mo (macrophages) and bone marrow cells in vitro upon stimulation with various biological response modifiers (BRMs). Optimal induction of CSF secretion occurred after in vitro treatment of peritoneal Mo and mononuclear bone marrow cells with 50 μg/ml poly ICLC (polyriboinosinic-polycytidylic acid poly-L-lysine), 5 μg/ml lipopolysaccharide (LPS), or 500 U/ml interferon (IFNα,β) for 2 days. The in vitro stimulation of CSF secretion was paralleled by an increase in PGE secretion by Mo and bone marrow cells. The PGE secretion could, however, be selectively blocked by preincubating the cells for 3 h with indomethacin (10−7 Mol) leaving CFS production intact. In vivo treatment of mice with either maleic anhydride divinyl ether copolymer (MVE-2; 25 mg/kg) or poly ICLC (2 mg/kg) significantly increased levels of CSF in serum, as well as in culture supernatants of in vivo-treated peritoneal Mo and bone marrow cells. The increase in serum CSF levels and in secretion of CSF by peritoneal Mo and bone marrow cells was followed by a dose-dependent increase in GM-CFU-C, in nucleated bone marrow cells, and in peripheral blood leukocytes. The same BRMs also stimulated the secretion of PGE by in vivo-activated peritoneal Mo, but not by bone marrow cells. Pretreatment of the mice with indomethacin (4 mg/kg) almost completely suppressed PGE secretion by peritoneal Mo, but did not change the CSF secretion by peritoneal Mo or bone marrow cells and had no significant effect on bone marrow cellularity. Therefore, MVE-2 and poly ICLC, in addition to their immunomodulatory activity, can also have stimulatory effects on myelopoiesis, presumably mediated through secretion of CSFs. Protection and/or restoration of bone marrow function could thus either provide the opportunity for more extensive chemotherapy or could increase the number of Mo effector cells available for activation against tumor targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bodey GP, Buckley M, Sathe YS, Freireich E (1966) Quantiative relationship between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med 64:328

    Google Scholar 

  2. Bradley TR, Stanley ER, Summer MA (1971) Factors from mouse tissues stimulating colony growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 49:595

    Google Scholar 

  3. Brunda MJ, Herberman RB, Holden HT (1980) Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124:2682

    Google Scholar 

  4. Chan SH, Metcalf D, Stanley ER (1971) Stimulation and inhibition of normal human serum of colony formation in vitro by bone marrow cells. Br J Haematol 20:329

    Google Scholar 

  5. Chirigos MA, Papademetriou V, Bartocci A, Read E, Levy HB (1981) Immune response modifying activity of polyinosinic: polycytidylic acid stabilized with poly-l-lysine in carboxymethylcellulose (poly ICLC). Int J Immunopharmol 3:329

    Google Scholar 

  6. Cline MJ, Golde DW (1974) Production of colony-stimulating activity by human lymphocytes. Nature 248:703

    Google Scholar 

  7. Das SK, Stanley ER, Guilbert LJ, Forman LW (1981) Human colony-stimulating factor radioimmunoassay: resolution of three subclasses of human colony-stimulating factors. Blood 58:630

    Google Scholar 

  8. Gidali J, Feher I, Talas M (1981) Proliferation inhibition of murine pluripotent haemopoietic stem cells by interferon or poly I:C. Cell Tissue Kinet 14:1

    Google Scholar 

  9. Jaffee BM, Behrman HR, Parker CW (1973) Radioimmunoassay measurement of prostaglandins E, A and F in human plasma. J Clin Invest 52:398

    Google Scholar 

  10. Klimpel GR, Fleischman WR, Klimpel KD (1982) Gamma interferon and IFNα,β suppress murine myeloid colony formation (CFU-C): magnitude of suppression is dependent upon level of colony stimulating factor (CSF). J Immunol 129:76

    Google Scholar 

  11. Kurland JI, Broxmeyer HE, Pelus LM, Bockman RS, Moore MAS (1978) Role for monocyte-macrophage derived colony stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. Blood 52:388

    Google Scholar 

  12. Ladisch S, Reaman GH, Poplack DG (1979) Bacillus Calmette-Guérin enhancement of colony stimulating activity and myeloid colony formation following administration of cyclophosphamide. Cancer Res 39:2544

    Google Scholar 

  13. Lohrmann HP, Schreml W (1982) Cytotoxic drugs and the granulopoietic system. Recent Results Cancer Res (Vol) 81

  14. Lusis AJ, Quan DH, Golde DW (1981) Purification and characterization of a human T lymphocyte-derived granulocyte-macrophage colony-stimulating factor. Blood 57:13

    Google Scholar 

  15. Metcalf D (1977) In vitro cloning of normal and leukemic cells. Recent Results Cancer Res (Vol) 61

  16. Metcalf D (1982) Regulatory control of proliferation and differentiation of normal and leukemia cells. Natl Cancer Inst Monogr 60:123

    Google Scholar 

  17. Metcalf D, Nicola NA (1982) Autoinduction of differentiation in Wehi-3B leukemia cells. Int J Cancer 30:773

    Google Scholar 

  18. Moore MAS (1979) Humoral regulation of granulopoiesis. Clin Haematol 8:287

    Google Scholar 

  19. Moore MAS, Williams N (1972) Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue. J Cell Physiol 80:195

    Google Scholar 

  20. Moore RN, Rouse BT (1983) Enhanced responsiveness of committed macrophage precursors to macrophage-type colony-stimulating factor (CSF-1) induced in vitro by interferons α + β. J Immunol 131:2374

    Google Scholar 

  21. Pelus LM, Broxmeyer HE, Kurland JI, Moore MAS (1979) Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med 150:277

    Google Scholar 

  22. Pouillart P, Palangié T, Schwarzenberg L, Brugerie H, Lhéritier I, Mathé G (1976) Effect of BCG on hematopoietic stem cells: experimental and clinical study. Cancer Immunol Immunotherapy 1:163

    Google Scholar 

  23. Ruscetti FW, Chervenick PA (1974) Release of colony stimulating factor from monocytes by endotoxin and polyinosinic-polycytidylic acid. J Lab Clin Med 83:64

    Google Scholar 

  24. Ruscetti FW, Chervenick PA (1974) Release of colony-stimulating activity from thymus-derived lymphocytes. J Clin Invest 55:520

    Google Scholar 

  25. Schlick E, Friedberg KD (1981) Bone marrow cells of mice under the influence of low lead doses. Arch Toxicol 49:227

    Google Scholar 

  26. Schlick E, Bartocci A, Chirigos MA (1982) Effect of azimexone on the bone marrow of normal and γ-irradiated mice. J Biol Resp Modif 1:179

    Google Scholar 

  27. Schlick E, Hartung K, Piccoli M, Bartocci A, Chirigos MA (1984a) The in vitro induction of colony stimulating factor, prostaglandin E and interferon in macrophages and tumor cells by biological response modifiers. In: Immunomodulating agents: properties and mechanisms. Chirigos, MA, and Fenichel R (eds) Marcel Dekker, New York (in press)

    Google Scholar 

  28. Schlick E, Hartung K, Chirigos MA (1984b) Role of prostaglandin E and interferon in secretion of colony-stimulating factor by murine macrophages after in vitro treatment with biological response modifiers. Int J Immunopharmacol (in press)

  29. Schlick E, Hartung K, Stevenson HC, Chirigos MA (1984c) Secretion of colony stimulating factors by human monocytes and bone marrow cells after in vitro treatment with biological response modifiers. J Leuc Biol (in press)

  30. Schultz RM, Pavlidis NA, Stylos WA, Chirigos MA (1978) Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science 202:320

    Google Scholar 

  31. Stanley ER, Guilbert LJ (1981) Methods for the purification, assay, characterization, and target cell binding of a colony stimulating factor (CSF). J Immunol Methods 42:253

    Google Scholar 

  32. Steel L, Kaliner M (1981) Prostaglandin — generating factor of anaphylaxis. J Biol Chem 256:12692

    Google Scholar 

  33. Sullivan R, Gans PJ, McCarroll LA (1983) The synthesis and secretion of granulocyte-monocyte colony stimulating activity (CSA) by isolated human monocytes: kinetics of the response to bacterial endotoxin. J Immunol 130:800

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Immunoregulation, National Cancer Institute-Frederick Cancer Research Facility, 21701, Frederick, MD, USA

    Erich Schlick

  2. Biological Therapeutics Branch, National Cancer Institute-Frederick Cancer Research Facility, 21701, Frederick, MD, USA

    Klaus Hartung & Michael A. Chirigos

Authors
  1. Erich Schlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael A. Chirigos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlick, E., Hartung, K. & Chirigos, M.A. Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers. Cancer Immunol Immunother 18, 226–232 (1984). https://doi.org/10.1007/BF00205516

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205516

Keywords

Search

Navigation